Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition

Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions

A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency

IRGM1 links mitochondrial quality control to autoimmunity